Peking University People's Hospital: Lung Neoplasms trials

The registry lists 30 Lung Neoplasms studies with Peking University People's Hospital as lead sponsor. 11 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 1No phase 25(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CTNot yet recruitingNCT07647692
• Clinical Study of a New Treatment Model for Elderly Lung Cancer PatientsRecruitingNCT07632664Not applicable
• Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2
• Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?Enrolling by invitationNCT07494006
• To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)RecruitingNCT07291921
• Impact of Perioperative Body Temperature on Postoperative Complications and Pain in Video-assisted Thoracoscopic Surgery Patients Utilizing Continuous Temperature MonitoringNot yet recruitingNCT07251439
• Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung CancerRecruitingNCT06930807Not applicable
• Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung CancerNot yet recruitingNCT06682884Phase 2
• The Effects of Programmed Death-ligand 1 on Postoperative Pain for Lung Cancer PatientsRecruitingNCT06503432
• Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR MutationNot yet recruitingNCT05962021Phase 2
• Multiomics Tumor Evolution Model of NSCLCRecruitingNCT05352035
• Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung CancerCompletedNCT07654036Not applicable
• Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)Status unknownNCT04817046
• A Preliminary Study on the Detection of Plasma Markers in Early Diagnosis for Lung CancerStatus unknownNCT04558255
• Detecting Lung Cancer Based on Exhaled BreathCompletedNCT04419207
• Evolution of Multiple Primary Lung Cancer (Evolution)Status unknownNCT04326751
• Detection of Lung Cancer by Plasma LipidsCompletedNCT04287712
• Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).Status unknownNCT03634826
• Early Diagnosis of Small Pulmonary Nodules by Multi-omics SequencingCompletedNCT03320044
• Multiplex Analysis of Circulating Tumor DNAStatus unknownNCT03301961
• Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer PatientsCompletedNCT02965391
• Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective StudyStatus unknownNCT02907606
• Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNAStatus unknownNCT02833467
• A Comparison Between EBUS-GS and CT-guided Lung Biopsy in Diagnosis of Peripheral Pulmonary Lesions.Status unknownNCT02740400Not applicable
• Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer PatientsStatus unknownNCT02696525
• Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung CancerCompletedNCT02645318
• Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and LobectomyStatus unknownNCT02360761Phase 3
• Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLCStatus unknownNCT01771289Phase 2
• VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung CancerStatus unknownNCT01707888
• Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01337037